Cell Proliferation Kit Market - Top Companies and Manufacturers

  • Report ID: 3860
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cell Proliferation Kit Landscape

    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • General Electric Company
    • PerkinElmer Inc.
    • F. Hoffmann-La Roche AG
    • Biotium, Inc.
    • Mindray Medical International Limited
    • Biological Industries

Browse Key Market Insights with Data Illustration:

In the News

  • Thermo Fisher Scientific, Inc. deals with EDF Renewables to provide with about 545,000 MWh of renewable power per year from the Millers Branch Solar project in Texas. Further, by 2026, all of the company's current U.S. facilities will be powered entirely by renewable energy with a goal to help the customers make the world healthier, cleaner, and safer.

  •  Biotium, Inc.  a provider of a provider of modern life science reagents, and Cell Data Sciences, a maker of RNAstorm and DNAstorm™ kits for RNA/DNA extraction, teamed up to provide a combined pricing for the DNAstormTM and RNAstormTM FFPE extraction kits in comparison to buying each kit separately.


Author Credits:  Radhika Pawar


  • Report ID: 3860
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cell proliferation kit is estimated at USD 624.96 Million.

The cell proliferation kit market size was valued at USD 559 Million in 2023 and is poised to cross USD 2.38 Billion by the end of 2036, registering more than 11.8% CAGR during the forecast period i.e., between 2024-2036. Increasing rate of patients diagnosed with cancer & tumors, and the rising conscious towards healthcare are the major factors driving the market growth.

North America is projected to hold largest industry share by 2036, due to the increasing frequency of new cancer cases such as melanoma, urothelial carcinoma, lung cancer, and others in the region.

Thermo Fisher Scientific, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, General Electric Company, PerkinElmer Inc., F. Hoffmann-La Roche AG, Biotium, Inc., Mindray Medical International Limited, Biological Industries
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample